Non-invasive oral cancer check in Fanconi anemia patients
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study uses a safe, non-invasive method to look at mouth growths in people with Fanconi anemia. It aims to better understand these lesions without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have Fanconi anemia.
- You must be 15 years old or older.
- You must have at least one mouth lesion (like a sore or spot), with or without warning signs.
- You must agree to take part in the study.
- You cannot be pregnant or breastfeeding.
- You cannot be legally protected (like under guardianship) or refuse to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how squamous cell carcinoma (a type of cancer) naturally develops over time in people with Fanconi anemia. It may help doctors better recognize warning signs and plan care in the future.
This study uses MRI (a safe imaging scan) to detect and track dangerous changes in the mouth of people with Fanconi Anemia, a rare genetic condition. The goal is to find a better way to catch oral cancer early.
This study observes and talks with adults with Fanconi anemia about their feelings during cancer screening visits. It aims to learn how to better support people with FA through screening anxiety.
This study looks at how a breakdown product from alcohol (acetaldehyde) may play a role in oral (mouth) cancer. It may help researchers understand who is more affected by alcohol and why.
This study compares two non-invasive methods to detect precancerous sores in the mouth. It aims to find a simpler way to catch early changes before they become cancer.
This trial tests an oral (mouth) screening approach to catch early, possibly cancer-pre-cursor changes. It may help you find warning spots sooner if you have specific mouth lesions.
Hear when a new Fanconi Anaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.